Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biperiden for Prevention of Post Traumatic Epilepsy
NCT04945213Phase 3Recruiting
- Sponsor
- Hospital Sírio-Libanês
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of biperiden in post-traumatic epilepsy (PTE), sponsored by Hospital Sírio-Libanês. Started Jan 2023; status: recruiting.
02
Drugs
biperiden
03
Conditions
post-traumatic epilepsy (PTE)
Beyond the preview
Go deeper on NCT04945213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04945213.